Infant Formula

FDA Calls on Infant Formula Industry to Strengthen Supplier Oversight

The letter highlights recent infant botulism and cereulide contamination cases and calls for increased vigilance by industry to ensure the safety of ingredients and infant formula products.

Rep. DeLauro Cites Infant Botulism Outbreaks in Call for Formula Safety Reform

Ron Simon & Associates Files Botulism Lawsuit Against Nara Organics on Behalf of 3-Month-Old Infant

Nara Organics Recalls Infant Formula Amid Multistate Botulism Investigation

More from Quality Assurance & Food Safety

Taylor Farms Removes Iceberg Lettuce Sourced from Mexico Amid Cyclospora Outbreak

FDA, CDC Tie Multistate Cyclospora Outbreak to Taco Bell Lettuce

BCG and CGF Release New Report on AI Usage by CPG and Retail Companies